Physician profile
Daniel Chakhalian
NPI 1780116897
$2,013.48
in general payments reported to CMS, 2019-2025
11 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $544 · 2022: $71.90 · 2023: $149 · 2024: $464 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $458.38 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $273.46 | 2024-2025 | Novosorb Btm |
| Stryker Corporation | $244.83 | 2025 | Variax, Na |
| Abbvie INC. | $217.09 | 2025 | |
| W. L. Gore & Associates, INC. | $200.52 | 2021-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Acera Surgical, INC. | $152.95 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $148.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $126.49 | 2023 | Endurant Iis |
| Motiva USA, LLC | $101.06 | 2025 | |
| Ethicon US, LLC | $71.90 | 2022 | |
| Crossroads Orthopedics, LLC | $17.94 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Chakhalian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.